特异性-话题@MedSci

#特异性#

563篇内容 | 2166人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1899359, encodeId=c1cd18993598e, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=J Hepatology：慢性乙肝患者的乙型肝炎核心特异性记忆B细胞的临床反应变化, objectType=article, longId=188594, objectId=2de618859436, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2de618859436, replyNumber=0, likeNumber=110, createdTime=2020-10-25, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2de618859436, moduleTitle=J Hepatology：慢性乙肝患者的乙型肝炎核心特异性记忆B细胞的临床反应变化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2de618859436)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899327, encodeId=88dd189932e40, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=Glenmark双特异性抗体GBR 1342治疗多发性骨髓瘤，喜获FDA孤儿药物指定, objectType=article, longId=179623, objectId=75b91e96234a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=75b91e96234a, replyNumber=0, likeNumber=51, createdTime=2019-12-10, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=75b91e96234a, moduleTitle=Glenmark双特异性抗体GBR 1342治疗多发性骨髓瘤，喜获FDA孤儿药物指定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=75b91e96234a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899349, encodeId=eebd1899349f0, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=J hepatology： HBV特异性CD4 T细胞的TNF-α/IFN-γ谱与慢性HBV感染中的肝损伤和病毒清除有关, objectType=article, longId=185403, objectId=2cf518540350, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2cf518540350, replyNumber=0, likeNumber=64, createdTime=2020-09-05, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2cf518540350, moduleTitle=J hepatology： HBV特异性CD4 T细胞的TNF-α/IFN-γ谱与慢性HBV感染中的肝损伤和病毒清除有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2cf518540350)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899316, encodeId=8ded18993163f, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=Nat Biotech | 针对肿瘤抗原异质性问题，提出CAR-T与BiTEs联合的免疫疗法，产生强有力的特异性抗肿瘤效应, objectType=article, longId=176417, objectId=1f141e6417a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f141e6417a6, replyNumber=0, likeNumber=61, createdTime=2020-05-20, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f141e6417a6, moduleTitle=Nat Biotech | 针对肿瘤抗原异质性问题，提出CAR-T与BiTEs联合的免疫疗法，产生强有力的特异性抗肿瘤效应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f141e6417a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899306, encodeId=d8f01899306fe, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=全球双特异性抗体的靶点大总结, objectType=article, longId=175216, objectId=9e481e5216d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9e481e5216d9, replyNumber=0, likeNumber=67, createdTime=2020-04-12, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9e481e5216d9, moduleTitle=全球双特异性抗体的靶点大总结, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9e481e5216d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899357, encodeId=e35f189935ee4, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=史上第一个实验性苏丹病毒特异性抗体治疗进展, objectType=article, longId=188141, objectId=a1401881412d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a1401881412d, replyNumber=0, likeNumber=60, createdTime=2020-10-17, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a1401881412d, moduleTitle=史上第一个实验性苏丹病毒特异性抗体治疗进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a1401881412d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899339, encodeId=40791899339ac, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=CLIN CHEM LAB MED：通过化学文库筛选治疗炎症性皮肤病的kallikrein-5特异性抑制剂？, objectType=article, longId=182347, objectId=85ef18234e5d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=85ef18234e5d, replyNumber=0, likeNumber=64, createdTime=2020-10-09, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=85ef18234e5d, moduleTitle=CLIN CHEM LAB MED：通过化学文库筛选治疗炎症性皮肤病的kallikrein-5特异性抑制剂？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=85ef18234e5d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899378, encodeId=eb6418993e89a, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=Nature: 癌症治疗的概念性突破：三特异性抗体靶向治疗方法, objectType=article, longId=193236, objectId=412b193236e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=412b193236e9, replyNumber=0, likeNumber=155, createdTime=2021-02-08, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=412b193236e9, moduleTitle=Nature: 癌症治疗的概念性突破：三特异性抗体靶向治疗方法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=412b193236e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899374, encodeId=1bc418993e4f7, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=JTO：默克PD-L1双特异性抗体显神威，1期结果显示在NSCLC的ORR可达36%, objectType=article, longId=192587, objectId=6b7419258e79, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6b7419258e79, replyNumber=0, likeNumber=63, createdTime=2021-01-31, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6b7419258e79, moduleTitle=JTO：默克PD-L1双特异性抗体显神威，1期结果显示在NSCLC的ORR可达36%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6b7419258e79)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899379, encodeId=0ab018993e9ca, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=罗氏诊断新冠病毒检测敏感性与特异性接近100%，FDA紧急批准上市, objectType=article, longId=193481, objectId=d2cf19348130, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d2cf19348130, replyNumber=0, likeNumber=51, createdTime=2021-02-22, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d2cf19348130, moduleTitle=罗氏诊断新冠病毒检测敏感性与特异性接近100%，FDA紧急批准上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d2cf19348130)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899380, encodeId=04761899380a1, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=Int Forum Allergy Rhinol：常年性鼻炎儿童的特异性舌下免疫治疗分析 , objectType=article, longId=193567, objectId=c42419356e9c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c42419356e9c, replyNumber=0, likeNumber=64, createdTime=2020-12-08, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c42419356e9c, moduleTitle=Int Forum Allergy Rhinol：常年性鼻炎儿童的特异性舌下免疫治疗分析 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c42419356e9c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899323, encodeId=d4e118993232b, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=黄慧强教授：淋巴瘤治疗进展显著，双特异性抗体等免疫治疗前景广阔, objectType=article, longId=178600, objectId=ebc71e860033, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ebc71e860033, replyNumber=0, likeNumber=61, createdTime=2020-07-11, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ebc71e860033, moduleTitle=黄慧强教授：淋巴瘤治疗进展显著，双特异性抗体等免疫治疗前景广阔, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ebc71e860033)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899296, encodeId=f2461899296f5, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=Arthritis Rheumatol：痛风中的病因特异性死亡率, objectType=article, longId=168018, objectId=6cb316801858, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6cb316801858, replyNumber=0, likeNumber=53, createdTime=2020-01-08, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6cb316801858, moduleTitle=Arthritis Rheumatol：痛风中的病因特异性死亡率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6cb316801858)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899298, encodeId=e8e818992989f, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=Bioorg Med Chem Lett：氧器可敏感且特异性地检测抗辐射鼻咽癌的生物标志物, objectType=article, longId=168506, objectId=dc451685067e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dc451685067e, replyNumber=0, likeNumber=64, createdTime=2020-05-02, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dc451685067e, moduleTitle=Bioorg Med Chem Lett：氧器可敏感且特异性地检测抗辐射鼻咽癌的生物标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dc451685067e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899338, encodeId=d6e5189933872, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=Allergol Immunopathol (Madr)：过敏性鼻炎患者中皮刺测试与血清特异性免疫球蛋白E相关性研究, objectType=article, longId=182105, objectId=1e1018210558, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e1018210558, replyNumber=0, likeNumber=60, createdTime=2019-11-18, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e1018210558, moduleTitle=Allergol Immunopathol (Madr)：过敏性鼻炎患者中皮刺测试与血清特异性免疫球蛋白E相关性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e1018210558)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899356, encodeId=c8ef1899356c6, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=Blood：JNJ-64407564，GPRC5DxCD3双特异性抗体，有望成为治疗MM的新选择！, objectType=article, longId=187901, objectId=4e1418e901c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e1418e901c3, replyNumber=0, likeNumber=61, createdTime=2020-08-24, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e1418e901c3, moduleTitle=Blood：JNJ-64407564，GPRC5DxCD3双特异性抗体，有望成为治疗MM的新选择！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e1418e901c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899305, encodeId=b6081899305dc, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=NAT MED：特异性基因编辑防止耳聋, objectType=article, longId=174960, objectId=0bf31e49601b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0bf31e49601b, replyNumber=0, likeNumber=56, createdTime=2020-05-03, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0bf31e49601b, moduleTitle=NAT MED：特异性基因编辑防止耳聋, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0bf31e49601b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899326, encodeId=41241899326de, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=Sci Rep：组织特异性孕酮受体-染色质结合和孕酮依赖的基因表达调控, objectType=article, longId=179165, objectId=91fd1e916510, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=91fd1e916510, replyNumber=0, likeNumber=66, createdTime=2020-05-20, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=91fd1e916510, moduleTitle=Sci Rep：组织特异性孕酮受体-染色质结合和孕酮依赖的基因表达调控, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=91fd1e916510)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899330, encodeId=3cc618993308e, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=Blood：血小板特异性抗体检测的新方法, objectType=article, longId=181206, objectId=86571812064d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=86571812064d, replyNumber=0, likeNumber=75, createdTime=2020-05-11, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=86571812064d, moduleTitle=Blood：血小板特异性抗体检测的新方法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=86571812064d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899289, encodeId=26081899289f7, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=Ann Rheum Dis：加拿大安大略省系统性红斑狼疮的全因、病因和年龄特异性标化死亡率, objectType=article, longId=164668, objectId=d7c216466818, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d7c216466818, replyNumber=0, likeNumber=61, createdTime=2020-03-02, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d7c216466818, moduleTitle=Ann Rheum Dis：加拿大安大略省系统性红斑狼疮的全因、病因和年龄特异性标化死亡率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d7c216466818)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

特异性

2020-05-29

jinweidong (审核中...)

前往app查看评论内容

#特异性#

J Hepatology：慢性乙肝患者的乙型肝炎核心特异性记忆B细胞的临床反应变化

2020-10-25

jinweidong (审核中...)

前往app查看评论内容

#特异性#

Glenmark双特异性抗体GBR 1342治疗多发性骨髓瘤，喜获FDA孤儿药物指定

2019-12-10

jinweidong (审核中...)

前往app查看评论内容

#特异性#

J hepatology： HBV特异性CD4 T细胞的TNF-α/IFN-γ谱与慢性HBV感染中的肝损伤和病毒清除有关

2020-09-05

jinweidong (审核中...)

前往app查看评论内容

#特异性#

Nat Biotech | 针对肿瘤抗原异质性问题，提出CAR-T与BiTEs联合的免疫疗法，产生强有力的特异性抗肿瘤效应

2020-05-20

jinweidong (审核中...)

前往app查看评论内容

#特异性#

全球双特异性抗体的靶点大总结

2020-04-12

jinweidong (审核中...)

前往app查看评论内容

#特异性#

史上第一个实验性苏丹病毒特异性抗体治疗进展

2020-10-17

jinweidong (审核中...)

前往app查看评论内容

#特异性#

CLIN CHEM LAB MED：通过化学文库筛选治疗炎症性皮肤病的kallikrein-5特异性抑制剂？

2020-10-09

jinweidong (审核中...)

前往app查看评论内容

#特异性#

Nature: 癌症治疗的概念性突破：三特异性抗体靶向治疗方法

2021-02-08

jinweidong (审核中...)

前往app查看评论内容

#特异性#

JTO：默克PD-L1双特异性抗体显神威，1期结果显示在NSCLC的ORR可达36%

2021-01-31

jinweidong (审核中...)

前往app查看评论内容

#特异性#

罗氏诊断新冠病毒检测敏感性与特异性接近100%，FDA紧急批准上市

2021-02-22

jinweidong (审核中...)

前往app查看评论内容

#特异性#

Int Forum Allergy Rhinol：常年性鼻炎儿童的特异性舌下免疫治疗分析

2020-12-08

jinweidong (审核中...)

前往app查看评论内容

#特异性#

黄慧强教授：淋巴瘤治疗进展显著，双特异性抗体等免疫治疗前景广阔

2020-07-11

jinweidong (审核中...)

前往app查看评论内容

#特异性#

Arthritis Rheumatol：痛风中的病因特异性死亡率

2020-01-08

jinweidong (审核中...)

前往app查看评论内容

#特异性#

Bioorg Med Chem Lett：氧器可敏感且特异性地检测抗辐射鼻咽癌的生物标志物

2020-05-02

jinweidong (审核中...)

前往app查看评论内容

#特异性#

Allergol Immunopathol (Madr)：过敏性鼻炎患者中皮刺测试与血清特异性免疫球蛋白E相关性研究

2019-11-18

jinweidong (审核中...)

前往app查看评论内容

#特异性#

Blood：JNJ-64407564，GPRC5DxCD3双特异性抗体，有望成为治疗MM的新选择！

2020-08-24

jinweidong (审核中...)

前往app查看评论内容

#特异性#

NAT MED：特异性基因编辑防止耳聋

2020-05-03

jinweidong (审核中...)

前往app查看评论内容

#特异性#

Sci Rep：组织特异性孕酮受体-染色质结合和孕酮依赖的基因表达调控

2020-05-20

jinweidong (审核中...)

前往app查看评论内容

#特异性#

Blood：血小板特异性抗体检测的新方法

2020-05-11

jinweidong (审核中...)

前往app查看评论内容

#特异性#

Ann Rheum Dis：加拿大安大略省系统性红斑狼疮的全因、病因和年龄特异性标化死亡率

2020-03-02

科室
- - 订阅+
  - 更多科室
工具
服务